Identification of an Inhibitor of the EWS-FLI1 Oncogenic Transcription Factor by High-Throughput Screening
Patrick J. Grohar(National Institutes of Health), Lee J. Helman(American Osteopathic Association), Duane Currier(St. Jude Children's Research Hospital), James B. McMahon(National Cancer Institute), Arnulfo Mendoza(National Institutes of Health), Girma M. Woldemichael(Division of Undergraduate Education), Choh Yeung(National Institutes of Health), Laurie B. Griffin(University of Michigan), Qing-Rong Chen(National Cancer Institute), Sean Davis(University Medical Center), Chand Khanna(Drug Discovery Laboratory (Norway)), Javed Khan(Kent State University)
Cited by 206
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
|Cancer Discovery|2014|789
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome
|Blood|2011|638
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
|Nature Genetics|2015|563